Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Jonathon R., Falzon, Dennis, Mirzayev, Fuad, Jaramillo, Ernesto, Migliori, Giovanni Battista, Mitnick, Carole D., Ndjeka, Norbert, Menzies, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Online Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826/
https://www.ncbi.nlm.nih.gov/pubmed/31922953
http://dx.doi.org/10.3201/eid2603.190997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826/
https://www.ncbi.nlm.nih.gov/pubmed/31922953
http://dx.doi.org/10.3201/eid2603.190997

Ejemplares similares